• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用自体富血小板血浆恢复卵巢功能。

Ovarian Function Restoration Using Autologous Platelet-Rich Plasma.

作者信息

Guo Zijia, Kawamura Kazuhiro

机构信息

Department of Obstetrics and Gynecology Juntendo University Graduate School of Medicine Tokyo Japan.

Department of Obstetrics and Gynecology Juntendo University Faculty of Medicine Tokyo Japan.

出版信息

Reprod Med Biol. 2025 Jul 16;24(1):e12666. doi: 10.1002/rmb2.12666. eCollection 2025 Jan-Dec.

DOI:10.1002/rmb2.12666
PMID:40678564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12267889/
Abstract

BACKGROUND

With the trend of delayed childbearing, the incidence of poor ovarian response (POR) with diminished ovarian reserve (DOR) and premature ovarian insufficiency (POI) has increased. Effective treatments for ovarian function restoration are limited. Platelet-rich plasma (PRP), an autologous regenerative therapy, shows potential for improving ovarian function; however, its mechanisms of action and optimal treatment protocols remain unclear.

METHODS

A literature review was conducted using PubMed and Google Scholar, covering studies published from January 2021 to March 2025, focusing on preclinical and clinical studies evaluating the effects of PRP on ovarian function.

MAIN FINDINGS

Preclinical studies indicate that PRP promotes primordial follicle activation and growth. It also enhances oocyte quality by promoting angiogenesis, exerting anti-inflammatory and antioxidative effects, and modulating the extracellular matrix. Clinically, PRP may increase the number of retrieved oocytes and improve certain ovarian reserve markers, but its impact on oocyte quality and pregnancy rates remains inconclusive. The optimal dosage and treatment duration also require further investigation.

CONCLUSIONS

PRP holds promise in reproductive medicine, but additional research is required to evaluate long-term effects, optimize treatment protocols, and standardize preparation methods.

摘要

背景

随着生育延迟的趋势,卵巢储备功能下降(DOR)和卵巢早衰(POI)导致的卵巢反应不良(POR)发生率有所上升。恢复卵巢功能的有效治疗方法有限。富血小板血浆(PRP)作为一种自体再生疗法,显示出改善卵巢功能的潜力;然而,其作用机制和最佳治疗方案仍不清楚。

方法

使用PubMed和谷歌学术进行文献综述,涵盖2021年1月至2025年3月发表的研究,重点关注评估PRP对卵巢功能影响的临床前和临床研究。

主要发现

临床前研究表明,PRP可促进原始卵泡的激活和生长。它还通过促进血管生成、发挥抗炎和抗氧化作用以及调节细胞外基质来提高卵母细胞质量。在临床上,PRP可能会增加获卵数并改善某些卵巢储备指标,但其对卵母细胞质量和妊娠率的影响仍无定论。最佳剂量和治疗持续时间也需要进一步研究。

结论

PRP在生殖医学中具有前景,但需要更多研究来评估其长期影响、优化治疗方案并规范制备方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/12267889/734a068b1c3b/RMB2-24-e12666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/12267889/734a068b1c3b/RMB2-24-e12666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/12267889/734a068b1c3b/RMB2-24-e12666-g001.jpg

相似文献

1
Ovarian Function Restoration Using Autologous Platelet-Rich Plasma.使用自体富血小板血浆恢复卵巢功能。
Reprod Med Biol. 2025 Jul 16;24(1):e12666. doi: 10.1002/rmb2.12666. eCollection 2025 Jan-Dec.
2
Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.自体富血小板血浆卵巢内注射治疗卵巢低反应患者的疗效:系统评价和荟萃分析。
Arch Gynecol Obstet. 2024 Jun;309(6):2323-2338. doi: 10.1007/s00404-024-07442-0. Epub 2024 Apr 8.
3
Evaluation of intraovarian injection of platelet-rich plasma for enhanced ovarian function and reproductive success in women with POI and POR: a systematic review and meta-analysis.评估卵巢内注射富血小板血浆对改善原发性卵巢功能不全(POI)和卵巢反应不良(POR)女性的卵巢功能及生殖成功率的影响:一项系统评价和荟萃分析。
Eur J Med Res. 2025 Jul 10;30(1):610. doi: 10.1186/s40001-025-02854-3.
4
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).针对接受体外受精加卵胞浆内单精子注射(IVF/ICSI)的女性,使用卵巢储备标志物进行个性化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Intraovarian injection of autologous platelet-rich-plasma: myth or reality?卵巢内注射自体富血小板血浆:神话还是现实?
Minerva Obstet Gynecol. 2025 Jun;77(3):192-204. doi: 10.23736/S2724-606X.24.05480-0. Epub 2024 Oct 10.
7
Randomized controlled trial to evaluate the impact of follicle priming on IVM outcomes in women with polycystic ovaries: CFA versus FSH-B.评估卵泡预处理对多囊卵巢女性体外成熟结局影响的随机对照试验:克罗米芬加促性腺激素释放激素拮抗剂方案与促卵泡生成素加促性腺激素释放激素拮抗剂方案的比较
Hum Reprod. 2025 Jun 1;40(6):1127-1137. doi: 10.1093/humrep/deaf053.
8
Enhancing oocyte activation in women with ovarian failure: clinical outcomes of the Stem Cell Regenera study using G-CSF mobilization of peripheral blood stem cells and intraovarian injection of stem cell factor-enriched platelet rich plasma in real-world-practice.增强卵巢功能衰竭女性的卵母细胞激活:干细胞再生研究的临床结果,该研究在实际临床实践中采用粒细胞集落刺激因子动员外周血干细胞以及向卵巢内注射富含干细胞因子的富血小板血浆
Aging (Albany NY). 2025 Jun 27;17(6):1571-1580. doi: 10.18632/aging.206274.
9
Autologous platelet-rich plasma for assisted reproduction.自体富血小板血浆在辅助生殖中的应用。
Cochrane Database Syst Rev. 2024 Apr 29;4(4):CD013875. doi: 10.1002/14651858.CD013875.pub2.
10
Single-cell analysis comparing early-stage oocytes from fresh and slow-frozen/thawed human ovarian cortex reveals minimal impact of cryopreservation on the oocyte transcriptome.单细胞分析比较新鲜和慢速冷冻/解冻的人类卵巢皮质中的早期卵母细胞,结果显示冷冻保存对卵母细胞转录组的影响极小。
Hum Reprod. 2025 Apr 1;40(4):683-694. doi: 10.1093/humrep/deaf009.

本文引用的文献

1
A highly sensitive Anti-Müllerian hormone test as a promising tool for follicle growth prediction in primary ovarian insufficiency patients.一种高灵敏度抗苗勒管激素检测作为预测原发性卵巢功能不全患者卵泡生长的有前景工具。
Sci Rep. 2025 Apr 23;15(1):14005. doi: 10.1038/s41598-025-98808-0.
2
Platelet-rich plasma promotes wound repair in diabetic foot ulcer mice via the VEGFA/VEGFR2/ERK pathway.富血小板血浆通过VEGFA/VEGFR2/ERK途径促进糖尿病足溃疡小鼠的伤口修复。
Growth Factors. 2024 Oct;42(4):161-170. doi: 10.1080/08977194.2024.2422014. Epub 2024 Nov 14.
3
Comparison of the efficacy of autologous Lp-PRP and Lr-PRP for treating intervertebral disc degeneration: in vitro and in vivo study.
自体富血小板血浆(Lp-PRP)与富含生长因子的富血小板血浆(Lr-PRP)治疗椎间盘退变的疗效比较:体外与体内研究。
J Orthop Surg Res. 2024 Nov 6;19(1):731. doi: 10.1186/s13018-024-05196-8.
4
Novel Advances in Cell-Free Therapy for Premature Ovarian Failure (POF): A Comprehensive Review.卵巢早衰(POF)无细胞疗法的新进展:综述
Adv Pharm Bull. 2024 Oct;14(3):543-557. doi: 10.34172/apb.2024.059. Epub 2024 Jul 31.
5
Novel Molecular Mechanisms Underlying the Ameliorative Effect of Platelet-Rich Plasma against Electron Radiation-Induced Premature Ovarian Failure.血小板富血浆对电子辐射诱导的卵巢早衰的改善作用的新分子机制。
Int J Mol Sci. 2024 Sep 20;25(18):10115. doi: 10.3390/ijms251810115.
6
Intraovarian PRP injection improves oocyte quality and early embryo development in mouse models of chemotherapy-induced diminished ovarian reserve.PRP 注射对化疗诱导的卵巢储备功能降低的小鼠模型的卵母细胞质量和早期胚胎发育有改善作用。
Aging (Albany NY). 2024 Sep 13;16(17):12123-12137. doi: 10.18632/aging.206099.
7
Intraovarian Platelet-Rich Plasma Administration for Anovulatory Infertility: Preliminary Findings of a Prospective Cohort Study.卵巢内注射富含血小板血浆治疗无排卵性不孕症:一项前瞻性队列研究的初步结果
J Clin Med. 2024 Sep 6;13(17):5292. doi: 10.3390/jcm13175292.
8
Ovarian fibrosis: molecular mechanisms and potential therapeutic targets.卵巢纤维化:分子机制与潜在治疗靶点。
J Ovarian Res. 2024 Jul 5;17(1):139. doi: 10.1186/s13048-024-01448-7.
9
Revitalizing female fertility: platelet-rich plasma - hype or hope?女性生育力的复兴:富血小板血浆——炒作还是希望?
Reprod Biomed Online. 2024 Aug;49(2):103813. doi: 10.1016/j.rbmo.2024.103813. Epub 2024 Jan 9.
10
Platelet-Rich Plasma (PRP) for Endometrial Treatment Efficacy and Safety in Assisted Reproductive Technology: A Comprehensive Review.富血小板血浆(PRP)用于辅助生殖技术中子宫内膜治疗的疗效与安全性:一项综述
Cureus. 2024 May 6;16(5):e59728. doi: 10.7759/cureus.59728. eCollection 2024 May.